ÂÜÀòÂÒÂ×

Sara Coblin is the Senior Vice President of Finance & Administration at the Parker Institute for Cancer Immunotherapy (PICI) and a member of the executive team and leads financial planning and accounting.

Sara comes to PICI with over 25 years of experience in financial planning, accounting, business development and strategic collaborations. Prior to PICI, she was the Vice President of Finance and Operations and a member of the Executive Committee at ORIC Pharmaceuticals. Prior to ORIC, Sara spent 11 years at Genentech/Roche supporting commercial and development collaborations with Roche, Biogen, and OSI Pharmaceuticals as well as leading global R&D and CMC financial planning.

Sara earned her MBA at the University of California, Berkeley Haas School of Business and her BA in Economics and Computer Applications at the University of Notre Dame.